cell line ccrfcem (Keygen Biotech)
90
Structured Review
Keygen Biotech
cell line ccrfcem
Cell Line Ccrfcem, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+line+ccrfcem/cell+line+ccrfcem/10__1016_slash_s1875___5364_ascii40_23_ascii41_60404___2-198-9-18
Average 90 stars, based on 1 article reviews
Cell Line Ccrfcem, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+line+ccrfcem/cell+line+ccrfcem/10__1016_slash_s1875___5364_ascii40_23_ascii41_60404___2-198-9-18
Average 90 stars, based on 1 article reviews
cell line ccrfcem - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
CCK-8 Assay:Article Title: Discovery and bioassay of disubstituted β-elemene-NO donor conjugates: synergistic enhancement in the treatment of leukemia Article Snippet: [ABSTRACT] Natural products are essential sources of antitumor drugs.. One such molecule, β-elemene, is a potent antitumor compound extracted from Curcuma wenyujin.. In the present investigation, a series of novel 13,14-disubstituted nitric oxide (NO)-donor βelemene derivatives were designed, with β-elemene as the foundational compound, and subsequently synthesized to evaluate their therapeutic potential against leukemia. Proliferation Assay:Article Title: Discovery and bioassay of disubstituted β-elemene-NO donor conjugates: synergistic enhancement in the treatment of leukemia Article Snippet: [ABSTRACT] Natural products are essential sources of antitumor drugs.. One such molecule, β-elemene, is a potent antitumor compound extracted from Curcuma wenyujin.. In the present investigation, a series of novel 13,14-disubstituted nitric oxide (NO)-donor βelemene derivatives were designed, with β-elemene as the foundational compound, and subsequently synthesized to evaluate their therapeutic potential against leukemia. |